Retail News CRM

Tag: China Jo-Jo Drugstores

  • Here is What Institutional Investors Think About China Jo-jo Drugstores Inc

    Here is What Institutional Investors Think About China Jo-jo Drugstores Inc

    China Jo-jo Drugstores Inc institutional sentiment decreased to 1 in 2015 Q3. Its down -1.50, from 2.5 in 2015Q2. The ratio is negative, as 5 investment professionals opened new or increased holdings, while 2 trimmed and sold equity positions in China Jo-jo Drugstores Inc. The investment professionals in our partner’s database now have: 783,924 shares, up from 321,572 shares in 2015Q2. Also, the number of investment professionals holding China Jo-jo Drugstores Inc in their top 10 holdings was flat from 0 to 0 for the same number.

    China Jo-Jo Drugstores, Inc. is a retailer and distributor of pharmaceutical and other healthcare products found in a retail pharmacy in the People’s Republic of China. The company has a market cap of $29.26 million. The Company’s operating divisions include retail drugstores, online pharmacy, wholesale business selling products similar to those the Company carries in its pharmacies, and farming and selling herbs used for traditional Chinese medicine . It has 33.31 P/E ratio. The Firm has 59 store locations under the store brand Jiuzhou Grand Pharmacy in Hangzhou.

    It is up 28.82% since August 11, 2015 and is downtrending. It has underperformed by 26.09% the S&P500.

    Analysts await China Jo-Jo Drugstores Inc to reports earnings on July, 4.

    According to Zacks Investment Research, “China Jo-Jo Drugstores, Inc., through its contractually controlled affiliates, operates a retail pharmacy chain in China offering both western and traditional Chinese medicine. Its contractually controlled affiliates include Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd., Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine General Partnership, and Hangzhou Jiuzhou Medical & Public Health Service Co., Ltd. The chain has stores throughout Hangzhou, the provincial capital of Zhejiang Province.”

    Sabby Management Llc holds 0.05% of its portfolio in China Jo-Jo Drugstores Inc for 614,149 shares. California Public Employees Retirement System owns 29,300 shares or 0% of their US portfolio. Moreover, Morgan Stanley has 0% invested in the company for 34,787 shares. The New York-based Renaissance Technologies Llc has invested 0% in the stock. Sabal Trust Co, a Florida-based fund reported 12,400 shares.

  • China Jo-Jo Drugstores turns a profit

    China Jo-Jo Drugstores turns a profit

    Chinese pharmacy retailer China Jo-Jo Drugstores has finally turned a profit, thanks to booming online sales and partnerships with health insurers.

    The US-listed retailer achieved second quarter sales of US$22.6 million, up 22.4 per cent on the same period last year. And it turned a loss of $40,000 last year into a $150,000 profit for the quarter.

    Year to date, revenue totaled $43.9 million up 25.7 per cent year on year, gross profit of $8.4 million was up 58.3 per cent and gross margin of 19 per cent compared to 15.1 per cent last year.

    “We are pleased with China’s Jo-Jo’s mid-year progress as the company continues to focus its efforts in growing the online pharmacy division which experienced triple-digit growth in the period,” commented Lei Liu, chairman and CEO.

    “ In large part, due to strategic cooperation with large insurance companies and fast-growing private healthcare insurance programs, our online pharmacy sales have expanded quickly in this quarter. The consumer demand for expanded online pharmacy services continues to play an integral role in the rebalancing of the company’s revenue mix while providing the opportunity to enhance organic sales growth at our physical chain drugstores,” he said.

    “China Jo-Jo continues to explore new sales and marketing channels to grow its consumer base including establishing programs to promote “mobile app” shopping with major vendors.”

    The company also continues to optimise its product mix across its online storefronts and physical stores.

    Retail drugstore sales, accounted for approximately 58 per cent of the total revenue for the three months ended September 30, and increased by $697,097, or 5.6 per cent.

    Same-store sales decreased by approximately $343,219, or 2.9 per cent, while new stores contributed $952,255 in revenue.

    Online pharmacy sales increased by approximately $3,609,016, or 122.4 per cent for the quarter. China Jo-Jo continues to operate several online pharmacy storefronts including China Jo-Jo’s own official branded store in addition to working with other B2C’s online platforms which direct customers back to China Jo-Jo’s own websites.

    Its own branded website sales in the quarter increased by 406.2 per cent, primarily as a result of the active cooperation with large insurance companies in China, to sell online products to customers who have purchased health insurance from them.

    Lees ook: